- Home
- OBIO vs VWAV Comparison
OBIO vs VWAV Comparison
Compare OBIO & VWAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBIO
- VWAV
- Stock Information
- Founded
- OBIO 2017
- VWAV 2024
- Country
- OBIO United States
- VWAV United States
- Employees
- OBIO N/A
- VWAV N/A
- Industry
- OBIO Medicinal Chemicals and Botanical Products
- VWAV Computer Software: Prepackaged Software
- Sector
- OBIO Health Care
- VWAV Technology
- Exchange
- OBIO Nasdaq
- VWAV Nasdaq
- Market Cap
- OBIO 147.8M
- VWAV 122.6M
- IPO Year
- OBIO N/A
- VWAV N/A
- Fundamental
- Price
- OBIO $2.75
- VWAV $10.05
- Analyst Decision
- OBIO Strong Buy
- VWAV
- Analyst Count
- OBIO 4
- VWAV 0
- Target Price
- OBIO $14.00
- VWAV N/A
- AVG Volume (30 Days)
- OBIO 339.4K
- VWAV 373.7K
- Earning Date
- OBIO 08-12-2025
- VWAV 08-19-2025
- Dividend Yield
- OBIO N/A
- VWAV N/A
- EPS Growth
- OBIO N/A
- VWAV N/A
- EPS
- OBIO N/A
- VWAV N/A
- Revenue
- OBIO $2,944,000.00
- VWAV N/A
- Revenue This Year
- OBIO $19.83
- VWAV N/A
- Revenue Next Year
- OBIO $12.53
- VWAV N/A
- P/E Ratio
- OBIO N/A
- VWAV N/A
- Revenue Growth
- OBIO 41.61
- VWAV N/A
- 52 Week Low
- OBIO $2.37
- VWAV $2.06
- 52 Week High
- OBIO $6.50
- VWAV $12.59
- Technical
- Relative Strength Index (RSI)
- OBIO 50.09
- VWAV N/A
- Support Level
- OBIO $2.65
- VWAV N/A
- Resistance Level
- OBIO $3.08
- VWAV N/A
- Average True Range (ATR)
- OBIO 0.16
- VWAV 0.00
- MACD
- OBIO 0.03
- VWAV 0.00
- Stochastic Oscillator
- OBIO 52.86
- VWAV 0.00
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About VWAV VisionWave Holdings Inc. Common Stock
VisionWave Holdings Inc is engaged in revolutionizing defense capabilities by integrating artificial intelligence (AI) and autonomous solutions across air, ground, and sea domains. Its innovations range from high-resolution radars and vision systems to radio frequency (RF) sensing technologies are seeking to redefine operational efficiency and precision for military and homeland security applications globally.